Conway's most recent trade in Plug Power Inc was a trade of 1,000,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Plug Power Inc | Gerard L. Conway | Gen. Coun, Corp Sec., Exec. VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Sep 2025 | 1,000,000 | 1,000,000 | - | - | Stock Option (Right to Buy) | |
| Carlyle Group Inc The | William E. Conway | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Sep 2025 | 2,000,000 | 26,999,644 (7%) | 0% | 0 | Common Stock | |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2025 | 274 | 8,338 (0%) | 0% | 0 | Common Stock | |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2025 | 274 | 274 | - | - | Restricted Stock Units | |
| Bellring Brands Inc | Shawn W. Conway | Director | Purchase of securities on an exchange or from another person at price $ 50018.30 per share. | 14 Aug 2025 | 1,316 | 8,001 (0%) | 0% | 50018.3 | 65,824,087 | Common Stock |
| Bellring Brands Inc | Shawn W. Conway | Director | Purchase of securities on an exchange or from another person at price $ 37.99 per share. | 14 Aug 2025 | 1,316 | 8,001 (0%) | 0% | 38.0 | 50,000 | Common Stock |
| Carlyle Group Inc The | William E. Conway | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Aug 2025 | 1,000,000 | 28,999,644 (8%) | 0% | 0 | Common Stock | |
| Bellring Brands Inc | Shawn W. Conway | Director | Purchase of securities on an exchange or from another person at price $ 36.41 per share. | 06 Aug 2025 | 2,700 | 6,685 (0%) | 0% | 36.4 | 98,307 | Common Stock |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 587 | 3,520 | - | - | Restricted Stock Units | |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 587 | 18,446 | - | - | Common Stock | |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. | 15 Jul 2025 | 173 | 18,273 | - | 0.4 | 74 | Common Stock |
| Bellring Brands Inc | Shawn W. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 546 | 3,164 | - | - | BellRing Brands, Inc. Common Stock Equivalents | |
| UnitedHealth | Patrick Conway | Chief Executive Officer, Optum | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 73 | 10,471 (0%) | 0% | 0 | Common Stock | |
| UnitedHealth | Patrick Conway | Chief Executive Officer, Optum | Sale of securities on an exchange or to another person at price $ 305.00 per share. | 10 Jun 2025 | 589 | 10,398 (0%) | 0% | 305 | 179,645 | Common Stock |
| UnitedHealth | Patrick Conway | Chief Executive Officer, Optum | Payment of exercise price or tax liability using portion of securities received from the company at price $ 296.08 per share. | 05 Jun 2025 | 667 | 11,147 (0%) | 0% | 296.1 | 197,485 | Common Stock |
| UnitedHealth | Patrick Conway | Chief Executive Officer, Optum | Payment of exercise price or tax liability using portion of securities received from the company at price $ 303.71 per share. | 05 Jun 2025 | 160 | 10,987 (0%) | 0% | 303.7 | 48,594 | Common Stock |
| UnitedHealth | Patrick Conway | Chief Executive Officer, Optum | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 6,550 | 6,550 | - | - | Non-Qualified Stock Options (right to buy) | |
| UnitedHealth | Patrick Conway | Chief Executive Officer, Optum | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 1,641 | 11,815 (0%) | 0% | 0 | Common Stock | |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 274 | 548 | - | - | Restricted Stock Units | |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2025 | 274 | 8,064 (0%) | 0% | 0 | Common Stock | |
| Northern Trust | Kelley Conway | Executive Vice President | Sale of securities on an exchange or to another person at price $ 105.28 per share. | 12 May 2025 | 500 | 12,213 (0%) | 0% | 105.3 | 52,640 | Common Stock |
| Plug Power Inc | Gerard L. Conway | Gen. Coun, Corp Sec., Exec. VP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.84 per share. | 05 May 2025 | 16,188 | 259,482 (0%) | 0% | 0.8 | 13,598 | Common Stock |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 587 | 4,107 | - | - | Restricted Stock Units | |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 587 | 18,032 | - | - | Common Stock | |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.37 per share. | 15 Apr 2025 | 173 | 17,859 | - | 0.4 | 64 | Common Stock |
| Bellring Brands Inc | Shawn W. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 425 | 2,617 | - | - | BellRing Brands, Inc. Common Stock Equivalents | |
| UMH Properties Inc | Kiernan Conway | Director | Grant, award, or other acquisition of securities at price $ 18.30 per share. | 25 Mar 2025 | 1,223 | 2,209 (0%) | 0% | 18.3 | 22,381 | UMH Properties, Inc. |
| McCormick & Company | Michael A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,344 | 0 | - | - | Restricted Stock Units | |
| McCormick & Company | Michael A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 1,344 | 16,630 (0%) | 0% | 0 | Common Stock - Voting | |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 275 | 7,790 (0%) | 0% | 0 | Common Stock | |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2025 | 275 | 822 | - | - | Restricted Stock Units | |
| Northern Trust | Kelley Conway | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 110.27 per share. | 18 Feb 2025 | 1,007 | 12,713 (0%) | 0% | 110.3 | 111,042 | Common Stock |
| Northern Trust | Kelley Conway | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 828 | 13,963 (0%) | 0% | 0 | Common Stock | |
| Northern Trust | Kelley Conway | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 112.69 per share. | 18 Feb 2025 | 243 | 13,720 (0%) | 0% | 112.7 | 27,384 | Common Stock |
| McCormick & Company | Michael A. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 2,222 | 2,222 | - | - | Restricted Stock Units | |
| Northern Trust | Kelley Conway | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 2,783 | 13,135 (0%) | 0% | 0 | Common Stock | |
| Salesforce | Craig A. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 1,097 | 1,097 | - | - | Restricted Stock Units | |
| Bellring Brands Inc | Shawn W. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2025 | 1,724 | 3,985 (0%) | 0% | 0 | Common Stock | |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 587 | 4,694 | - | - | Restricted Stock Units | |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2025 | 587 | 17,649 | - | - | Common Stock | |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.89 per share. | 15 Jan 2025 | 204 | 17,445 | - | 0.9 | 181 | Common Stock |
| Generation Bio Co | Kevin Conway | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 355,260 | 355,260 | - | - | Stock Option (right to buy) | |
| UMH Properties Inc | Kiernan Conway | Director | Grant, award, or other acquisition of securities at price $ 18.20 per share. | 07 Jan 2025 | 831 | 986 (0%) | 0% | 18.2 | 15,124 | UMH Properties, Inc. |
| Bellring Brands Inc | Shawn W. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 353 | 2,192 | - | - | BellRing Brands, Inc. Common Stock Equivalents | |
| Nutanix Inc - Ordinary Sha... | Craig A. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 3,646 | 43,097 (0%) | 0% | 0 | Class A Common Stock | |
| Carlyle Group Inc The | William E. Conway | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2024 | 2,000,000 | 29,999,644 (8%) | 0% | 0 | Common Stock | |
| UMH Properties Inc | Kiernan Conway | Director | Sale of securities on an exchange or to another person at price $ 18.93 per share. | 02 Dec 2024 | 1,045 | 141 (0%) | 0% | 18.9 | 19,782 | UMH Properties, Inc. |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 330 | 0 | - | - | Restricted Stock Units | |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 330 | 7,515 (0%) | 0% | 0 | Common Stock | |
| Plug Power Inc | Gerard L. Conway | Gen. Coun, Corp Sec., Exec. VP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.52 per share. | 06 Nov 2024 | 14,610 | 275,670 (0%) | 0% | 2.5 | 36,817 | Common Stock |
| Bellring Brands Inc | Shawn W. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 439 | 1,838 | - | - | BellRing Brands, Inc. Common Stock Equivalents | |
| UMH Properties Inc | Kiernan Conway | Director | Grant, award, or other acquisition of securities at price $ 19.65 per share. | 25 Sep 2024 | 770 | 1,186 (0%) | 0% | 19.7 | 15,131 | UMH Properties, Inc. |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 330 | 330 | - | - | Restricted Stock Units | |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 330 | 7,185 (0%) | 0% | 0 | Common Stock | |
| Starbucks | Michael A. Conway | ceo, North America | Sale of securities on an exchange or to another person at price $ 94.03 per share. | 15 Aug 2024 | 3,250 | 75,053 (0%) | 0% | 94.0 | 305,598 | Common Stock |
| UMH Properties Inc | Kiernan Conway | Director | Sale of securities on an exchange or to another person at price $ 19.54 per share. | 15 Aug 2024 | 2,700 | 412 (0%) | 0% | 19.5 | 52,758 | UMH Properties, Inc. |
| Bellring Brands Inc | Shawn W. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 466 | 1,399 | - | - | BellRing Brands, Inc. Common Stock Equivalents | |
| UMH Properties Inc | Kiernan Conway | Director | Grant, award, or other acquisition of securities at price $ 15.38 per share. | 20 Jun 2024 | 983 | 3,081 (0%) | 0% | 15.4 | 15,119 | UMH Properties, Inc. |
| Enterprise Bancorp Inc | James F. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 1,223 | 37,420 (0%) | 0% | 0 | Common Stock | |
| Starbucks | Michael A. Conway | ceo, North America | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 14 Jun 2024 | 3,250 | 78,303 (0%) | 0% | 80 | 260,000 | Common Stock |
| Salesforce | Craig A. Conway | Director | Sale of securities on an exchange or to another person at price $ 240.07 per share. | 11 Jun 2024 | 5,323 | 6,855 (0%) | 0% | 240.1 | 1,277,866 | Common Stock |
| Salesforce | Craig A. Conway | Director | Sale of securities on an exchange or to another person at price $ 236.26 per share. | 11 Jun 2024 | 677 | 12,178 (0%) | 0% | 236.3 | 159,949 | Common Stock |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 330 | 12,855 (0%) | 0% | 0 | Common Stock | |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2024 | 330 | 660 | - | - | Restricted Stock Units | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 50,000 | 0 (0%) | 0% | - | Common Stock | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 17,500 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 10,000 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 7,650 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 3,075 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 2,868 | 0 | - | - | Stock Option (Right to buy) | |
| Alpine Immune Sciences Inc | Robert E. Conway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 May 2024 | 1,912 | 0 | - | - | Stock Option (Right to buy) | |
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 13 May 2024 | 15,219 | 0 (0%) | 0% | 16.7 | 254,807 | Ordinary Shares | |
| Plug Power Inc | Gerard L. Conway | Gen. Coun, Corp Sec., Exec. VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 119,134 | 319,499 (0%) | 0% | 0 | Common Stock | |
| Plug Power Inc | Gerard L. Conway | Gen. Coun, Corp Sec., Exec. VP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.52 per share. | 09 May 2024 | 14,610 | 304,889 (0%) | 0% | 2.5 | 36,817 | Common Stock |
| Plug Power Inc | Gerard L. Conway | Gen. Coun, Corp Sec., Exec. VP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.08 per share. | 09 May 2024 | 14,609 | 290,280 (0%) | 0% | 2.1 | 30,387 | Common Stock |
| Plug Power Inc | Gerard L. Conway | Gen. Coun, Corp Sec., Exec. VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 750,000 | 750,000 | - | - | Stock Option (Right to Buy) | |
| Starbucks | Michael A. Conway | ceo, North America | Sale of securities on an exchange or to another person at price $ 85.39 per share. | 15 Apr 2024 | 3,250 | 81,198 (0%) | 0% | 85.4 | 277,518 | Common Stock |
| Bellring Brands Inc | Shawn W. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 451 | 932 | - | - | BellRing Brands, Inc. Common Stock Equivalents | |
| McCormick & Company | Michael A. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 3,732 | 3,732 | - | - | Options - Right to Buy | |
| McCormick & Company | Michael A. Conway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 1,344 | 1,344 | - | - | Restricted Stock Units | |
| UMH Properties Inc | Kiernan Conway | Director | Grant, award, or other acquisition of securities at price $ 15.66 per share. | 26 Mar 2024 | 966 | 2,083 (0%) | 0% | 15.7 | 15,128 | UMH Properties, Inc. |
| McCormick & Company | Michael A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 1,255 | 0 | - | - | Restricted Stock Units | |
| McCormick & Company | Michael A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 1,255 | 15,286 (0%) | 0% | - | Common Stock - Voting | |
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 05 Mar 2024 | 4,954 | 16,646 (0%) | 0% | - | Ordinary Shares | ||
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 05 Mar 2024 | 4,954 | 4,957 | - | - | Restricted Share Units | ||
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 05 Mar 2024 | 1,427 | 15,219 (0%) | 0% | 13.5 | 19,286 | Ordinary Shares | |
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 03 Mar 2024 | 33,482 | 33,482 | - | - | Restricted Share Units | ||
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 03 Mar 2024 | 7,117 | 13,734 (0%) | 0% | - | Ordinary Shares | ||
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 03 Mar 2024 | 7,117 | 14,237 | - | - | Restricted Share Units | ||
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 03 Mar 2024 | 5,179 | 8,107 (0%) | 0% | - | Ordinary Shares | ||
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 03 Mar 2024 | 5,179 | 15,538 | - | - | Restricted Share Units | ||
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 03 Mar 2024 | 2,042 | 11,692 (0%) | 0% | 13.4 | 27,308 | Ordinary Shares | |
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 03 Mar 2024 | 1,490 | 6,617 (0%) | 0% | 13.4 | 19,926 | Ordinary Shares | |
| Teva Pharmaceutical Industries | Vikki L. Conway | See "Remarks" | 28 Feb 2024 | 4,294 | 4,294 (0%) | 0% | - | Ordinary Shares | ||
| Teva Pharmaceutical Industries | Vikki Conway L. | See "Remarks" | 28 Feb 2024 | 4,294 | 0 | - | - | Restricted Share Units | ||
| Teva Pharmaceutical Industries | Conway L. Vikki | See "Remarks" | 28 Feb 2024 | 1,366 | 2,928 (0%) | 0% | 13.1 | 17,916 | Ordinary Shares | |
| Salesforce | Craig A. Conway | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 331 | 990 | - | - | Restricted Stock Units |